Amedisys Inc
NASDAQ:AMED
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89.45
98.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Amedisys Inc
Amedisys Inc
Net Change in Cash
Amedisys Inc
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Net Change in Cash
$151.4m
|
CAGR 3-Years
128%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Net Change in Cash
$613.5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Change in Cash
$621m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
29%
|
CAGR 10-Years
48%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Change in Cash
-$6.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
30%
|
CAGR 10-Years
-33%
|
|
|
Cigna Corp
NYSE:CI
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
41%
|
CAGR 10-Years
1%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Change in Cash
$789.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
Amedisys Inc
Glance View
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 21,000 full-time employees. The firm operates through four segments: Home Health, Hospice, Personal Care and high acuity care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The firm owns and operates approximately 530 care centers in 38 states.
See Also
What is Amedisys Inc's Net Change in Cash?
Net Change in Cash
151.4m
USD
Based on the financial report for Sep 30, 2024, Amedisys Inc's Net Change in Cash amounts to 151.4m USD.
What is Amedisys Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
87%
Over the last year, the Net Change in Cash growth was 142%. The average annual Net Change in Cash growth rates for Amedisys Inc have been 128% over the past three years , 87% over the past five years .
You don't have any saved screeners yet
